搜索到 1000 条关于 ㉶ 벳인포 ㈄ ray800.top ㆇ 축구토토 승무패 ㅮ 축구토토 승무패 ㄼ 야구토토배당률 ㉬ 실시간파워볼 ㈑ 벳인포스포츠토토 ㆂ 스포츠사이트 ㅨ 복권정보 的文章

2012.09.19 第四届复旦国际神经病学论坛--神经变性疾病的转化医学研究

的学费800元,资料费200元, 食宿代为安排,住宿费用自理,学员可获得国家级继续教育I类学分10分。欢迎广大临床医师和研究人员踊跃报名参加。联系人:复旦大学

2012.09.19 中华医学会超声医学分会第十一次全国超声医学学术会议

论文摘要一份,每篇800-1000字,请务必以目的、方法、结果、结论格式书写摘要内容。2. 参加中青年英语论坛者,只需附格式相同的英文摘要一份。(摘要前请

2012.09.19 第八次全国脑电图与癫痫诊治进展高级讲授班及学术研讨会

800~1000字的论文摘要1份。摘要请按目的、方法、结果、结论的结构形式撰写。会议采用Email方式投稿,作者及单位请标注于文题下,文后注明联系电话

2012.09.19 中华医学会显微外科学分会首届“中国显微外科青年论坛”

积极参与并讨论。会议期间召开中华医学会显微外科分会全体青年委员会会议。征文要求:⑴论文未公开发表;⑵来搞寄800字以内四段式摘要及全文,并详细注明作者姓名

2012.09.19 海峡两岸品质经营与创新服务管理论坛

,每团限20人)三、费用标准:会务费:800元/人/期,食、宿及交通费用自理。为方便各位院长沟通交流,我们将统一安排食宿,请各位代表提前预订

2012.09.19 第二届全国乳腺癌论坛(南京)

年7月16日全天网上报名:www.jsbreastcancer.com会议费用:会务费(含资料费、学分证费)5月31日前800元,6月1日至

2012.09.19 第十一次全国血液学术会议

://www.csh-cma.org.cn在线投稿系统投稿。本次会议不接受邮寄稿件。3.所投稿件应是未公开发表及未在全国学术会议上交流过的论文,600~800字摘要1份

2012.09.19 2010年全国神经外科麻醉年会

新技术产业园区榕苑路1号 300384)会务费:800元(食宿费自理,会议统一安排)注:为了保证您按时返回,提醒您订购往返机票或车票,谢谢

2012.09.19 国际脊柱创新发展学会第二届亚太学年会(APSAS)

论文摘要。注册费:即日起提前网上注册费一律RMB800元/人,现场注册费1000元/人。注册代表食宿将得到优先安排。

2012.09.19 2010年北京第四届疝和腹壁外科国际学术研讨会

、并发症的防治等方面的稿件在大会上交流,本次大会高质量的论文将安排作者在大会上发言并且在中华疝和腹壁外科杂志(电子版)上陆续刊登。本次会议会务费800元/每人,资料

2012.07.27 第十届全国胃病学术大会

。3.要求:1)未公开发表过,内容科学,数据准确,书写规范,摘要800字内,全文3000字内;2)欢迎特殊、疑难病例讨论投稿

2020.06.17 【直播 | 现场】计算机辅助设计—分子模拟与蛋白互作研讨班(8.20-22)

。【报名回执】访问此链接填写报名回执(https://www.wjx.top/jq/80710449.aspx)【咨询请联系】QQ 号:2814500767邮箱

2012.09.19 2011年生物仿制药会议(Biosimilars Asia 2011)

时间: 2011-5-23 至 2011-5-26
地点:Grand Hyatt Shanghai
主办单位: IBC Asia (S) Pte Ltd

会议简介

According to Business Insights, an estimated $25bn worth of biologics will lose patent protection by 2016, creating a significant market opportunity for biosimilars. However, the reality is that biosimilar development is a risk-fraught activity that demands significant resources in R&D, manufacturing expertise, regulatory know-how, clinical-trial capabilities, and a high level of financial investment.

Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry. It is estimated that it costs between US$100-200 million to bring a biosimilar product to market. With so much at stake, biosimilars represent not only substantial growth but equally risk..

IBC’s 2nd Annual Biosimilars Asia 2011 Summit is the ONLY conference in Asia catering to this region’s specific queries. With unprecedented insights from leading innovators and biosimilar companies, you will network and learn how to strategically position your company to maximize your ROI. Biosimilars Asia 2011 is attended by key stakeholders in the region and beyond, enabling you to make informed strategic decisions.

5 Reasons To Attend
  • Only conference in Asia which addresses concerns faced by the Asian biosimilar companies with experts from the region and beyond
  • Learn from and personally meet senior executives from the major stakeholders amongst from biosimilar to innovator companies
  • The most comprehensive event highlighting key challenges in the industry including manufacturing, marketing, pricing, transitioning from generics to biosimilars and regulatory issues
  • Showcasing unique case studies from leading Asian and international biosimilar companies
  • Gather the latest insights from regional biosimilar companies and MNCs about their strategic decisions and how they are positioning themselves for success

Industry Gurus / Speakers
Biocon, Pfizer, Genentech, Roche, Teva, Hospira, Sandoz, Momenta, Intas, Dr Reddy’s, Shenzhen Main Luck Pharmaceuticals

Past Attendees Include
Vice President, ASTRAZENECA INNOVATION CENTER (China)
Senior Director, GENENTECH INC, (USA)
Managing Director, BECTON DICKINSON CO (BD BIOSCIENCES) (Singapore)
Managing Director, ASAHI GLASS CO LTD (Japan)
Deputy General Manager, SINOPHARM (China)
Head, Biotech Research, USV LTD (India)
General Manager, JCR PHARMACEUTICALS CO LTD (Japan)
Vice President, R&D/Business Development, MAIN LUCK PHARMACEUTICALS INC (China)
Senior Research Associate, HANWHA CHEMICAL (South Korea)
Vice President, BOEHRINGER INGELHEIM GMBH (Germany)
General Manager, GLAXOSMITHKLINE (CHINA) INVESTMENT CO LTD (China)
IP Director, HOSPIRA (AUSTRALIA)
President, MYCENAX BIOTECH INC (Taiwan)
Senior Director, MERCK & CO INC (USA)
Associate Director, DR REDDY''''''''S LABORATORIES LTD (India)
Chairman, SHENZHEN SCIPROGEN BIO-PHARMACEUTICAL CO LTD (SCIPROGEN) (China)COO, SHANGHAI CELGEN BIOPHARMACEUTICALS (China)
Chief Representative, TTY BIOPHARM CO LTD (Taiwan)COO, 3SBIO (China)
Project Director, JIANGSU CHIA TAI TIANQING PHARMACEUTICAL CO LTD (China)Associate Director, PFIZER INVESTMENT CO LTD (China)
General Manager, NIPPON KAYAKU CO LTD (Japan)
President, HENLIUS BIOPHARMACEUTICALS INC & SHANGHAI HENLIUS BIOTECH (USA)
Vice President, RANBAXY (USA)

Registration

FEES per delegate
Early Bird Rate
Register & Pay before 11 March 2011
Special Rate
Register & Pay before 15 April 2011
Normal Rate
Register & Pay after 15 April 2011
Group Rate
Group of 3 or more
?
US$ / CNY
US$ / CNY
US$ / CNY
US$ / CNY
4 day package
(Conf + Pre & Post Workshops)
2,495 /
16,600
2,695 /
17,950
2,895 /
19,500
2,175 /
14,650
3.5 day package (Conf + Workshop C & A or B )

2,295 /
15,500

2,495 /
16,600
2,695 /
17,950
2,025 /
13,500
3 day package (Conf + Workshop A & B or C)
1,995 /
13,500
2,195 /
14,600
2,395 /
15,950

1,795 /
12,000

2.5 day package (Conf + Workshop A or B)
1,795 /
12,000
1,995 /
13,500
2,195 /
14,600
1,695 /
10,950
2 day package
(Conf only)
1,495 /
9,950
1,695 /
11,300
1,895 /
12,600
1,495 /
9,950

Register Now

PAYMENT TERMS

Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry cut-off date, registration and payment must be received by the cut off date.

Payments by Singapore Dollars (S$)

  • Payments by S$ bank draft or cheque should be made in favour of “IBC Asia (S) Pte Ltd” payable in Singapore.
  • Payment by telegraphic transfer in S$ must be made to:
    IBC Asia (S) Pte Ltd
    A/C No.: 147-059513-001 (SGD)
    The Hongkong and Shanghai Banking Corporation Limited
    21 Collyer Quay, HSBC Building, Singapore 049320
    Bank Swift Code: HSBCSGSG
    Bank Code: 7232
  • Payment by Credit Card (AMEX, VISA or MASTERCARD). Please provide your Card Number, Name of Cardholder, Expiry Date and your Signature and send it by fax to +65 6508 2407.
Payments by RMB (CNY)
  • Payment by telegraphic transfer in CNY must be made to:
    A/C Name:
    A/C No.: 720-031103-001
    Beneficiary Bank:
    Bank Address: No. 1000 Lujiazui Rind Road,
    Pudong, Shanghai 200120, P.R. China
    Bank Swift Code: HSBCCNSH
CANCELLATIONS SUBSTITUTION
Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event.IMPORTANT NOTE:
Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407.

Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC Asia will not be responsible for any event re-scheduled or cancelled.


DATA PROTECTION
The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Sometimes your details may be obtained from or shared with external companies for marketing purposes. If you do not wish your details to be used for this purpose, please contact Winnie Seah (Database) on winnie.seah@ibcasia.com.sg Tel: +65 6508 2468 or Fax: +65 6508 2408.
联系方式电话:+65 650 82401
卒中后抗血小板出血风险有多大?有这10个特征需谨慎

2017.08.13 卒中后抗血小板出血风险有多大?有这10个特征需谨慎

)(即 S2TOP-BLEED 评分模型,见表1)。表 1 预测严重出血的S2TOP-BLEED 评分(来自多变量 Cox 回归模型)具体评分方法为,根据患者临床特征评估 S2TOP-BLEED 评分列表中每一栏分值,除了年龄相关的项目外,将其他所有项目分值想加得总分,再将总分代入图 1 所示风险分布图中,得到不同
远程协作治疗创伤后应激障碍

2014.12.23 远程协作治疗创伤后应激障碍

明,使用远程医疗工具,如电话,互动视频和共享电子病历进行的多学科PTSD非现场干预,即创伤后应激障碍远程医疗服务(TOP)与常规护理(UC)相比,治疗效果显著提升...包括了2009年11月至2011年9月份在CBOCs接受治疗的265名主要生活在农村的退伍军人。所有患者均符合PTSD诊断标准,他们被随机分配接受TOP治疗(N

2012.09.19 中华医学会放射学分会第十九次全国放射学学术会议

论文摘要一份。摘要按中华医学会系列杂志稿约要求撰写,字数为800字左右,文体为论文标准结构式,包括目的、材料与方法、结果、结论四要素,摘要中不要...,会议注册费为600元/人;8月1日之后注册并缴费者,会议注册费为800元/人;10月18日现场注册并缴费者,会议注册费为1000元/人。

2012.09.19 2012全国小儿神外(春季)学术研讨会暨第一届中美小儿神外高峰论坛

域。3.小儿神经外科基础护理及围手术期护理。二、征稿要求:全文或500-800字摘要一份。摘要格式包括目的、方法、结果、结论。文稿请写明作者地址...注册的参会人员会务费为800元/人。

2012.09.19 2010年全国麻醉学术年会暨第十二届国际心胸麻醉会议

。二、征文要求:(一)、年会征文:1、凡报送参加年会交流的论文,均提交论文摘要一份(800--1000字以内),并请在稿件左上角按上述...,均需提交中、英论文摘要各一份(800--1000字以内)及中文全文一份,论文一律用word文档撰写(请网上投稿);征文要求同上;并请在稿件右上角
说好的 PLUS 会员来啦!说明书上传 3 月排行榜出炉

2022.04.06 说好的 PLUS 会员来啦!说明书上传 3 月排行榜出炉

到了 825 份说明书,经过后台小助手日以继夜的审核,最终角逐出「3 月说明书上传榜」前三名:Top 1: 楠楠一沐 有效说明书 43 份Top 2: Eric_xzt 有效说明书 20 份Top 3: dxy_00wxf3se
上一页 1 2 3 ... 43 44 45 ... 48 49 50 下一页 到第